Abstract: A system includes a catalytic reactor configured to mount to a combustor. The catalytic reactor includes a catalyst configured to reduce emissions associated with combustion in the combustor. The catalytic reactor also includes a first sacrificial coating disposed over the catalyst prior to mounting of the catalytic reactor into the combustor, wherein the first sacrificial coating is removable while the catalytic reactor is mounted to the combustor without damaging the catalyst.

Abstract: The invention generally relates to Pro-Drugs of dihydroorotate dehydrogenase (DHODH) inhibitors and methods of use thereof. In certain embodiments, the invention provides a DHODH inhibitor compound including a cleavable functional group that increases bioavailability as compared to a form of the DHODH inhibitor without the functional group, rendering the former more suitable for therapeutic use.

Abstract: A macro element template is replicated to build a macro element library. A macro element is associated with executable instructions for controlling a plurality of production devices to produce a special effect or segment of a media production. One or more automation control objects are positioned onto a control interface to build a macro element template. Build information is associated with each automation control object to assign a variable name, device type, property page field(s), and variable naming table. A replicator control interface allows a range of sources to be assigned to the macro element template, and is associated with executable instructions for building the macro element library. The macro element library includes user-defined filenames that enables a director to quickly search and select a desired macro element. Changes in production values ripple throughout the macro element library to dynamically update the macro elements.

Abstract: The invention generally relates to aminopyridines and methods of use thereof. In certain embodiments, the invention provides an aminopyridine or a pharmaceutically-acceptable salt thereof, in which the aminopyridine or the salt thereof includes a cleavable functional group that substantially prevents extra-hepatic hydrolysis.

Abstract: A coating process, a coating, and a coated component are disclosed. The coating process includes providing a MCrAlY substrate, applying a thermal barrier coating to the MCrAlY substrate, applying a flash layer to the thermal barrier coating, the flash layer including an inert ceramic, applying a reaction product deposition onto the thermal barrier coating, the reaction product deposition including reaction products selected from the group consisting of a magnesium oxide compound, a magnesium orthovanadate compound, a magnesium vanadate compound, a magnesium pyrovanadate compound, a magnesium sulfate compound, and combinations thereof. The reaction products are by-products of a doped fuel.

Abstract: An animal control system for use in a plant to facilitate management of the trapping of animals in the plant, the system including: a plurality of animal traps located at discrete locations of the plant, each trap including an animal sensor associated with the trap for detecting an animal trapped in the trap and a transceiver in electronic communication with the animal sensor, the transceiver having an identifier unique to the trap with which it is associated; and a computer system having a plurality of computers in communication with one another for receiving and reporting information relating to conditions of the traps. The discrete locations of the traps are obtained and input into a computer processor for processing to yield a computer generated template of the plant having a template of the plant with the discrete locations of the traps.

Abstract: A method for applying a protective coating to gas turbine engine components using a saturated solution of nickel acetate tetrahydrate, applying a uniform thickness of the coating onto the thermal barrier coating of selected components, and heat treating the coated component in air at a temperature sufficient to form a protective layer of NiO. The saturated NiO solution has sufficient solubility to penetrate into the microscopic cracks of the thermal barrier coating to form a “sacrificial mitigation layer” of NiO that substantially inhibits the reaction between vanadium pentoxide and yttria-stabilized compounds present in the thermal barrier coating.

Abstract: The present invention generally relates to the production of direct expanded farinaceous food products without the use of a drying apparatus such as an oven and without the use of traditionally used sugar to eliminate such drying steps. A farinaceous material combined with a plasticizer component in the form of trehalose is extruded to form a direct expanded shelf-stable snack food product. Snack food products made with trehalose can be incorporated into an outer shell of a composite center-filled or co-extruded product.

Abstract: A dual-textured food substrate having large seasoning bits whereby the bits are substantially adhered to the food substrate, or chip with a dry adhesive. The food substrate has a non-particulate second topping that is softer than the food substrate. The underlying cooked food substrate is substantially flat. The food ingredient properties are optimized to provide a shelf-stable dual-textured food product.

Abstract: A load-bearing structure, such as a pylon or strut, having a monolithic tubular-shaped first central structure composed of composite material and a plurality of metal fittings for supporting an engine on an airframe structure of an aircraft, such as a wing. Most of the fittings are integrated into the load-bearing structure through bonding. The metal fittings carry the high bearing loads that are transmitted into the pylon at the engine-pylon and wing-pylon interfaces. The load-bearing structure may also include a second central structure of a tubular shape composed of composite material and integrated with one end portion of the first central structure by bonding and/or mechanical fasteners.

Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.

Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.

Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.

Abstract: The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine—H3 receptor antagonist or inverse agonist activity, as well as methods and intermediates for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.

Abstract: A method for purchasing an item using a mobile device is provided. The method includes but is not limited to inputting identification information into the mobile device which identifies the item for purchase and generating an order for the item identified by the identification information. The method also includes but is not limited to displaying on a display of the mobile device an optical machine-readable representation of the order.

Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.

Abstract: In one embodiment, a method for drilling a wellbore includes an act of drilling the wellbore by injecting drilling fluid through a tubular string disposed in the wellbore, the tubular string comprising a drill bit disposed on a bottom thereof. The drilling fluid exits the drill bit and carries cuttings from the drill bit. The drilling fluid and cuttings (returns) flow to a surface of the wellbore via an annulus defined by an outer surface of the tubular string and an inner surface of the wellbore. The method further includes an act performed while drilling the wellbore of measuring a first annulus pressure (FAP) using a pressure sensor attached to a casing string hung from a wellhead of the wellbore. The method further includes an act performed while drilling the wellbore of controlling a second annulus pressure (SAP) exerted on a formation exposed to the annulus.

Abstract: A multi-mount apparatus for devices such as camera heads or lights on the end of a crane arm is disclosed. The multi-mount can include two substantially parallel side plates connected together with internal support members. A top mounting plate can be rotatably attached to the multi-mount at a top pivot point on the side plates. The multi-mount contains a leveling head, which can include a motor that drives a worm gear engaged with a moon gear. A bottom mounting plate can be attached to the moon gear, which is rotatably attached to the multi-mount at a bottom pivot point on the side plates. A motor drives a moon gear to rotate and maintain the bottom mounting plate at a desired orientation. In some embodiments, one or more push/pull rods rotatably attached to the bottom and top mounting plates also cause the top mounting plate to be maintained at the same orientation as the bottom mounting plate.

Abstract: Legumes having a raw moisture content of between about 19% to about 45% are pressure cooked to a moisture content of between about 42% to about 49%. The legumes may also be subjected to a low thermal stress dewatering at less than about 160° F. After grinding, additional ingredients such as starches, fibers, protein, and/or vitamin and mineral fortification can be added prior to forming a legume-based dough. Kneaded or shaped dough can be cooked and seasoned to make a nutritious snack food comprising between about 5 and about 6 grams of protein per one ounce serving, or between about 10%-30% protein.

Abstract: The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases. (Formula I).